Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen in Rumination Syndrome
NCT03113396Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Feb 2012
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of baclofen in rumination syndrome and supragastric belching (SGB), sponsored by UZ Leuven. Primary endpoint: Overall wellbeing at 2 weeks. Started Feb 2012; status: completed.
02
Drugs
baclofen
03
Conditions
rumination syndromesupragastric belching (SGB)
Beyond the preview
Go deeper on NCT03113396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03113396.